This TWIV (This Week in Virology) podcast episode covers various public health and virology topics. Discussions include potential transmission routes of H5N1 bird flu in dairy cattle, with a focus on "milk snatching" behavior, and current outbreaks of vaccine-preventable diseases like pertussis (whooping cough) and measles, highlighting rising case numbers and the importance of vaccination. The hosts examine the latest data on RSV prophylaxis with nirsevimab, showing no immediate resistance concerns, and provide an update on increasing COVID-19 cases and hospitalizations. A significant portion of the episode reviews the limited real-world effectiveness of the Sinopharm inactivated COVID-19 vaccine and explores therapeutic strategies for acute COVID-19 and long COVID, including the use of GLP-1 receptor agonists for Mast Cell Activation Syndrome (MCAS). The episode concludes with listener feedback, including a detailed critique from a veterinarian regarding the podcast's H5N1 coverage and a broader discussion on scientific communication and "COVID gaslighting."
Exploring Current Viral Outbreaks, Vaccine Efficacy, and Public Health Challenges
0:28 Hepatitis & Persistence in Science: The episode opens with a nod to hepatitis B and a discussion on the remarkable persistence required for breakthroughs like those in hepatitis C research, emphasizing the ongoing need for testing and treatment.
2:40 A Poetic Start & American Ideals: Vincent reads "The New Colossus" from the Statue of Liberty, connecting his upcoming "around Long Island race" with the American ideal of welcoming immigrants.
5:02 H5N1 in Dairy Cattle: Exploration of H5N1 bird flu transmission in dairy cattle, including a "milk snatching" theory where cows might transmit the virus from mouth to udder, though its relevance in industrial settings is questioned.
8:58 Pertussis Outbreak in Mississippi: A significant increase in whooping cough cases in Mississippi (80 cases in 2025 vs. 49 in 2024 total) is highlighted, with many hospitalizations among young children and infants. The importance of Tdap vaccination for close contacts of newborns is stressed.
11:21 Rising Measles Cases: The US has 1,319 confirmed measles cases by July 22, 2025, across 40 jurisdictions, surpassing post-elimination numbers and continuing to rise despite the summer season. Canada also reports nearly 4,000 cases.
12:40 Record Pediatric Flu Deaths: The 2024-2025 flu season recorded 261 influenza-associated pediatric deaths, the highest in a non-pandemic season, with most being vaccine-preventable.
13:17 RSV Prophylaxis & Resistance Monitoring: A study on nirsevimab prophylaxis for RSV in Western Australia found no evidence of viral resistance or lineage shifts, offering initial reassurance while acknowledging the need for continued surveillance.
15:40 Concerning COVID-19 Trends: US COVID-19 cases and hospitalizations are increasing, particularly in Western and Southern states, with pediatric hospitalizations on the rise, suggesting a possible shift towards a "double peak" seasonal pattern.
18:29 Sinopharm COVID-19 Vaccine Effectiveness: A real-world study in Mozambique showed the inactivated Sinopharm vaccine to be only 18% effective against symptomatic COVID-19, consistent with other findings on lower efficacy compared to mRNA or protein-based vaccines.
21:44 COVID-19 Treatment Strategies: Guidelines for COVID-19 treatment emphasize early antiviral therapy (e.g., Paxlovid) for at-risk individuals to reduce severe outcomes and long COVID risk, and the judicious use of steroids in later stages for patients with oxygen desaturation.
24:45 Long COVID & MCAS Treatment with GLP-1 Agonists: The podcast explores Mast Cell Activation Syndrome (MCAS) as a long COVID phenotype, discussing a study where GLP-1 receptor agonists showed significant clinical benefit (89% in 47 patients) based on a symptom-driven diagnostic approach.
29:57 Newborn Vaccine Recommendations: New parents are advised to ensure all close contacts are vaccinated against flu, COVID, Tdap (pertussis booster), and RSV to protect infants, especially during peak respiratory illness seasons.
31:11 Low-Dose Naltrexone (LDN) for Long COVID: LDN is discussed as an experimental treatment for long COVID, requiring compounded medication and careful titration, with ongoing studies to determine its efficacy.
32:39 Critique of COVID "Gaslighting" & Scientific Discourse: A listener's email praises the podcast's honest portrayal of the "Jon Snow memorandum" versus the "Great Barrington Declaration," lamenting the politicization and "gaslighting" that marred scientific discussion during the pandemic.
36:50 Veterinary Perspective & H5N1 Discussion: A veterinary immunologist provides detailed feedback, correcting H5N1 reporting inaccuracies, emphasizing the complexities of animal depopulation, and advocating for dedicated veterinary virology expertise on the podcast for future One Health discussions.
41:53 Pronunciation Debates: The episode concludes with a lighthearted discussion on the pronunciation of "Thimerosal" and "Apoptosis," highlighting differences between reading and hearing scientific terms.